<DOC>
	<DOCNO>NCT00029510</DOCNO>
	<brief_summary>Asthma currently affect estimate 15 million Americans . A number study find association low dietary magnesium ( Mg ) intake increase asthma incidence severity symptom . However , clinical intervention trial necessary directly ass whether true protective preventative causal relationship low Mg asthma . In study , assess effect 6 1/2 month oral Mg supplement placebo clinical marker asthma control , indirect biomarkers inflammation , bronchial hyperresponsiveness , index oxidative defense damage subject mild moderate persistent asthma .</brief_summary>
	<brief_title>Magnesium Asthma - Clinical Trials</brief_title>
	<detailed_description>Over past twenty year number study acute bronchial asthma show i.v . nebulized MgS04 may improve symptom course hour . With respect dietary supplementation , short term ( 3 wk ) oral Mg associate significant decrease symptom significant effect measurement like FEV1 bronchial hyperreactivity methacholine challenge . Although large number study attempt address issue , believe major gap still exist . One gap comparison large number asthmatic non-asthmatics , regard dietary intake , variety measure Mg status . We evaluate baseline Mg intake ( diet , tap bottle drinking water , vitamin-mineral supplement , laxative , antacid ) , multiple measure Mg status , total free serum Mg , total erythrocyte Mg , Mg retention IV Mg load subject without asthma . Furthermore large-scale study evaluate effect Mg supplementation asthma control clinical marker , marker inflammation . We propose assess effect 6 1/2 month oral Mg clinical marker asthma control ( asthma symptom diary , monthly spirometry , asthma quality life questionnaire ( QOL ) ) , indirect biomarkers inflammation ( exhaled nitric oxide serum eosinophil cationic protein ) bronchial hyperresponsiveness ( methacholine challenge ) subject mild moderate persistent asthma . Dietary Mg assess use 24 hr recall . Our hypothesis 1 . ) subject mild moderate persistent asthma , define National Institutes Health National Asthma Education Prevention Program ( NIH NAEPP ) clinical guideline poorer Mg status nonasthmatics , 2 . ) marginal Mg intake status may modulate severity asthma . Thus , subject asthma marginal intake/status thus relatively low total free plasma Mg , low erythrocyte total Mg , high Mg retention show improvement aforementioned clinical indirect biomarkers . In contrast , Mg supplement little effect subject high intake Mg status . We anticipate Mg supplementation replace conventional treatment , may complement decrease need conventional medication .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Mild moderate persistent asthma ( NAEPP 1997 revise guideline ) Current use inhale beta2 agonist steroid inhaler therapy ( No use prednisone past 3 month ) No use product ( i.e . antacid , laxative , supplement ) contain 50 mg Mg daily last 3 month No current use theophylline , leukotriene antagonist , systemic immunomodulating compound Nonsmoker No concurrent pulmonary disease ( pulmonary hypertension , cystic fibrosis , sarcoidosis , bronchiectasis , hypersensitivity pneumonitis , restrictive lung disease , abnormal DLCOva ) No concurrent medical diagnosis ( alcoholism , coronary artery disease , diabetes , HIV infection , chronic hepatitis , uncontrolled hypertension , chronic renal failure psychiatric disorder judge make full participation difficult ) Not pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>